Wedbush raised its price target on bluebird bio (NASDAQ: BLUE) to $225.00 (from $174.00) while maintaining an Outperform rating after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE